The Global Human Microbiome Market is estimated to be valued at US$ 4894.33 Mn in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the human microbiome market are Diageo plc, Pernod-Ricard SA, Constellation Brands Inc., Brown-Forman Corporation, Remy Cointreau SA, Marie Brizard Wine & Spirits, Lapostolle SA, and Berentzen-Gruppe AG. Rising awareness about gut health and the link between gut health and overall well-being has boosted demand for products in the human microbiome market. Several studies have linked alterations in the gut microbiome to various diseases like diabetes, obesity, cardiovascular diseases and more. As a result, people are increasingly consuming probiotic and prebiotic supplements to maintain a healthy gut microbiome.

The global Human Microbiome Market Size  has been expanding rapidly. The market in the Asia Pacific region especially is growing at a brisk pace owing to rising income levels, growing health consciousness and increasing prevalence of lifestyle diseases. Moreover, manufacturers are focusing on expanding their presence in emerging economies to tap the potential opportunities. North America currently dominates the global market due to high consumer awareness and heavy investments in R&D activities by key players.

Market Drivers

One of the major market drivers is the growing popularity of nutraceuticals and functional foods & beverages fortified with probiotics. There is rising consumer awareness about the various health benefits of consuming probiotic supplements and food and beverages. Probiotics help restore intestinal balance, boost immunity, aid digestion and more. As such, many yogurts, juices, teas and other food and drinks now contain added probiotic strains. This is positively impacting the growth of the human microbiome market.

Current Geopolitical Situation Is Impacting The Growth Of The Human Microbiome Market And Future Strategies:

The ongoing geopolitical tensions and restrictions across many regions of the world due to Covid-19 pandemic are posing challenges for the growth of the human microbiome market. The lockdowns and travel bans implemented by many countries to curb the spread of the virus have disrupted global supply chains and logistics to an extent. This has led to delays in delivery of critical products and research tools required by laboratories and research facilities studying the human microbiome. Furthermore, the shifting focus of research funding towards Covid vaccine and therapeutic development has also impacted ongoing research projects related to human microbiome.
Get more insights on Human Microbiome Market